Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07300046 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Tolerability Study of Liquid Metformin (100 and 250 mg/mL) vs IR Tablets

StatusNot Yet Recruiting
PhasePhase 1
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated December 23, 2025 (before its estimated August 15, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
This is an open-label, randomized study evaluating the tolerability of two concentrations of liquid metformin formulations (100 mg/mL and 250 mg/mL) compared with standard immediate-release metformin tablets in healthy adult subjects. Each participant will receive single oral doses of study treatments in a randomized sequence. Safety and tolerability will be assessed through adverse event monitoring, gastrointestinal symptom evaluations, vital signs, clinical laboratory tests, and ECGs.
Trial Details
NCT Number NCT07300046
Lead Sponsor Aspargo Labs, Inc
Conditions
(from sponsor)		 Healthy Volunteers
Enrollment 24 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov